Bioceres Crop Solutions Corp. BIOX
0.37
0.00
0.00%
as of 25 Sep
- Market cap
- $23.5M
- P/E
- 0.0×
Follow BIOX
Growth Flags
show if company had growth for consecutive years
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.85 | 0.28 | 0.28 | 0.11 | |
P/FCF ratio |
6.38 | 1.66 | 1.06 | 0.36 | |
P/Operating CF |
10.56 | 6.22 | 4.78 | 1.65 | |
P/B ratio |
0.96 | 0.31 | 0.78 | 0.27 | |
Price to Tangible BV |
150.17 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.22 | 0.67 | 0.67 | 0.50 | |
EV/EBITDA |
20.35 | 8.37 | 10.57 | 7.28 | |
EV/Operating CF |
8.13 | 3.58 | 2.38 | 1.64 | |
EV/FCF |
9.16 | 3.92 | 2.48 | 1.71 | |
Quick Ratio |
0.65 | 0.65 | 0.56 | 0.56 | |
Current Ratio |
0.91 | 0.94 | 0.90 | 0.88 | |
Net Debt/EBITDA |
(8.22) | 9.38 | 12.82 | 0.00 | |
Debt/Assets |
20.68% | 18.91% | 22.17% | 22.75% | |
Debt/Equity |
0.53 | 0.48 | 1.17 | 1.26 | |
Asset Turnover |
0.41 | 0.41 | 0.42 | 0.41 | |
Operating CF/Net income |
(0.56) | (1.96) | (0.09) | 0.00 | |
Capex/Depreciation |
(0.05) | (0.12) | 0.03 | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.05% | 7.40% | 3.18% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
51.45% | 29.95% | 23.23% | 0.00% | |
Intangible Assets out of Total Assets |
0.38 | 0.40 | 0.22 | 0.23 | |
Share Based Compensation of Revenue |
1.28% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.57) | (1.83) | (1.92) | (6.05) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(18.12%) | (59.57%) | (283.97%) | (857.78%) | |
Free Cash Flow Yield |
15.68% | 60.35% | 94.44% | 274.38% | |
Revenue per Share |
1.27 | 1.22 | 1.16 | 0.62 | |
Operating CF per Share |
0.42 | 0.23 | 0.27 | 0.00 | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.42 | 0.22 | 0.27 | 0.00 | |
Cash per Share |
0.55 | 0.26 | 0.20 | 0.23 | |
Shareholders Equity per Share |
4.67 | 4.55 | 1.68 | 1.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.67 | 4.55 | 1.68 | 1.50 | |
Free Cash Flow |
26.52 | 13.67 | 17.43 | — | |
Working Capital |
(29.67) | (16.56) | (34.36) | (36.80) | |
Capital Expenditures |
(0.25) | (0.70) | 0.04 | — | |
Net Current Asset Value |
(160.11) | (163.40) | (159.47) | (173.20) | |
EV/EBIT |
0.00 | 81.35 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.00 | |
Net Profit Margin |
(59.45%) | (9.49%) | (248.00%) | (22.84%) | |
Price to Operating Income |
0.00 | 34.36 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
204.93 | 198.21 | 208.67 | 178.07 | |
Average Payables |
132.58 | 123.03 | 116.72 | 104.10 | |
Average Inventory |
108.11 | 105.12 | 86.68 | 73.11 | |
Average Assets |
808.10 | 781.07 | 697.78 | 663.91 | |
Average Common Equity |
323.30 | 317.18 | 226.47 | — |
Columns are period end dates